AU2017237093B2 - Compositions and methods of treatment with amniotic fluid - Google Patents

Compositions and methods of treatment with amniotic fluid Download PDF

Info

Publication number
AU2017237093B2
AU2017237093B2 AU2017237093A AU2017237093A AU2017237093B2 AU 2017237093 B2 AU2017237093 B2 AU 2017237093B2 AU 2017237093 A AU2017237093 A AU 2017237093A AU 2017237093 A AU2017237093 A AU 2017237093A AU 2017237093 B2 AU2017237093 B2 AU 2017237093B2
Authority
AU
Australia
Prior art keywords
composition
amniotic fluid
modified
compositions
amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2017237093A
Other languages
English (en)
Other versions
AU2017237093A1 (en
Inventor
Thomas J. Koob
Michelle MASSEE
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mimedx Group Inc
Original Assignee
Mimedx Group Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mimedx Group Inc filed Critical Mimedx Group Inc
Publication of AU2017237093A1 publication Critical patent/AU2017237093A1/en
Application granted granted Critical
Publication of AU2017237093B2 publication Critical patent/AU2017237093B2/en
Priority to AU2023201219A priority Critical patent/AU2023201219A1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Reproductive Health (AREA)
  • Immunology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Botany (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Vascular Medicine (AREA)
  • Birds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
AU2017237093A 2016-03-23 2017-03-23 Compositions and methods of treatment with amniotic fluid Active AU2017237093B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2023201219A AU2023201219A1 (en) 2016-03-23 2023-02-28 Compositions and methods of treatment with amniotic fluid

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201662312391P 2016-03-23 2016-03-23
US201662312379P 2016-03-23 2016-03-23
US201662312403P 2016-03-23 2016-03-23
US62/312,391 2016-03-23
US62/312,403 2016-03-23
US62/312,379 2016-03-23
PCT/US2017/023893 WO2017165698A1 (en) 2016-03-23 2017-03-23 Compositions and methods of treatment with amniotic fluid

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2023201219A Division AU2023201219A1 (en) 2016-03-23 2023-02-28 Compositions and methods of treatment with amniotic fluid

Publications (2)

Publication Number Publication Date
AU2017237093A1 AU2017237093A1 (en) 2018-10-18
AU2017237093B2 true AU2017237093B2 (en) 2022-12-01

Family

ID=59899764

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2017237093A Active AU2017237093B2 (en) 2016-03-23 2017-03-23 Compositions and methods of treatment with amniotic fluid
AU2023201219A Abandoned AU2023201219A1 (en) 2016-03-23 2023-02-28 Compositions and methods of treatment with amniotic fluid

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2023201219A Abandoned AU2023201219A1 (en) 2016-03-23 2023-02-28 Compositions and methods of treatment with amniotic fluid

Country Status (5)

Country Link
US (2) US10960027B2 (enExample)
EP (1) EP3432896A4 (enExample)
JP (1) JP2019513136A (enExample)
AU (2) AU2017237093B2 (enExample)
WO (1) WO2017165698A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9526770B2 (en) 2011-04-28 2016-12-27 Tissuetech, Inc. Methods of modulating bone remodeling
US20190167862A1 (en) * 2015-03-04 2019-06-06 Pensara, Inc Collection of amniotic fluid for wound healing
JP2019513136A (ja) * 2016-03-23 2019-05-23 ミメディクス グループ インコーポレイテッド 羊水による治療の組成物及び方法
US20170354692A1 (en) * 2016-06-13 2017-12-14 MAM Holdings of West Florida, L.L.C. Amniotic fluid formulation for treatment of lung disorders
US10869953B2 (en) 2018-12-13 2020-12-22 James Glenn Norman Shield for recurrent laryngeal nerve and associated methods
US10342631B1 (en) * 2018-12-13 2019-07-09 James Glenn Norman Shield for recurrent laryngeal nerve and associated method of use
US10933164B2 (en) 2018-12-13 2021-03-02 James Glenn Norman Methods for protecting a parathyroid
EP3930734A4 (en) * 2019-02-28 2022-12-07 Merakris Therapeutics, LLC EXTRACELLULAR VESICLES DERIVED FROM AMBIENT WATER AND THEIR USES IN WOUND HEALING
JP7099714B2 (ja) * 2019-04-25 2022-07-12 株式会社グランツーク研究所 噴霧用美容液
TR201917367A2 (tr) * 2019-11-08 2021-05-21 Ercuement Ovali Saç dökülmesi̇ ve skar tedavi̇si̇nde kullanima uygun bi̇r ürünün üreti̇mi̇ i̇çi̇n bi̇r yöntem
US12377121B2 (en) * 2020-04-10 2025-08-05 Zeo Scientifix, Inc. Compositions comprising nanoparticles, method of making and uses thereof
US11485451B2 (en) 2021-02-03 2022-11-01 Jetts, Llc Jet sled
WO2022236015A1 (en) * 2021-05-07 2022-11-10 Regenerative Science, Inc. Amniotic cytokine formulations
US12213994B2 (en) 2021-12-08 2025-02-04 Zeo Scientifix, Inc. Compositions and methods for treating pain with extracellular vesicles
WO2024206871A1 (en) * 2023-03-30 2024-10-03 Cetel Scientific Llc Amniotic and chorionic collagen for ocular surface healing
WO2025034980A1 (en) * 2023-08-08 2025-02-13 Mimedx Group, Inc. Pourable placental collagen matrix sheet

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006091546A2 (en) * 2005-02-22 2006-08-31 The Johns Hopkins School Of Medicine Use of amniotic fluid (af) in treating ocular disease and injury
US20140336600A1 (en) * 2013-05-10 2014-11-13 Carl Randall Harrell Method for Obtaining Sterile Human Amniotic Fluid and Uses Thereof
US20150024483A1 (en) * 2011-04-26 2015-01-22 Neil H. Riordan Therapeutic conditioned media
WO2015134946A1 (en) * 2014-03-06 2015-09-11 Amnio Technology Llc Amnion derived therapeutic compositions and methods of use
WO2015171142A1 (en) * 2014-05-07 2015-11-12 Osiris Therapeutics, Inc. Therapeutic placental compositions, methods of making and methods of use
US20160067287A1 (en) * 2014-09-09 2016-03-10 Mimedx Group, Inc. Micronized placental tissue compositions with optional sealant and methods of making and using the same

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1696958A (en) * 1927-03-02 1929-01-01 Herbert L Johnson Therapeutic agent for treatment of bodily lesions
US3689668A (en) * 1967-10-18 1972-09-05 Emile Leon Piette Method of alleviating wrinkles on skin
JPS5251010A (en) * 1975-10-22 1977-04-23 Morinaga Milk Ind Co Ltd Method of producing drug for treating marrow
US8932805B1 (en) * 2011-10-31 2015-01-13 BioDlogics, LLC Birth tissue material and method of preparation
JP5828802B2 (ja) * 2012-05-07 2015-12-09 英伸 太田 早産児用の抱っこ型次世代人工保育器。
US10485521B2 (en) * 2013-05-10 2019-11-26 MAM Holdings of West Florida, L.L.C. Method for obtaining sterile human amniotic fluid and uses thereof
US20160000968A1 (en) * 2014-07-07 2016-01-07 Mimedx Group, Inc. Placental tissue grafts and improved methods of preparing and using the same
US11129856B2 (en) 2015-03-03 2021-09-28 Prime Merger Sub, Llc Methods of treating chronic wounds with amniotic fluid having elevated levels of tissue inhibitors of matrix metalloproteinases
US11077149B1 (en) * 2015-03-04 2021-08-03 Pensara, Inc Method for the collection and use of amniotic fluid
MA45272A (fr) 2015-06-27 2018-05-02 Stimlabs Llc Produits issus de liquide amniotique et procédés d'utilisation
US10413572B2 (en) 2015-08-11 2019-09-17 Vivex Biomedical, Inc. Liquid amnion transplant product
US10517903B2 (en) 2015-09-14 2019-12-31 Amnio Technology Llc Amnion derived therapeutic composition and process of making same
JP2019513136A (ja) * 2016-03-23 2019-05-23 ミメディクス グループ インコーポレイテッド 羊水による治療の組成物及び方法

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006091546A2 (en) * 2005-02-22 2006-08-31 The Johns Hopkins School Of Medicine Use of amniotic fluid (af) in treating ocular disease and injury
US20150024483A1 (en) * 2011-04-26 2015-01-22 Neil H. Riordan Therapeutic conditioned media
US20140336600A1 (en) * 2013-05-10 2014-11-13 Carl Randall Harrell Method for Obtaining Sterile Human Amniotic Fluid and Uses Thereof
WO2015134946A1 (en) * 2014-03-06 2015-09-11 Amnio Technology Llc Amnion derived therapeutic compositions and methods of use
WO2015171142A1 (en) * 2014-05-07 2015-11-12 Osiris Therapeutics, Inc. Therapeutic placental compositions, methods of making and methods of use
US20160067287A1 (en) * 2014-09-09 2016-03-10 Mimedx Group, Inc. Micronized placental tissue compositions with optional sealant and methods of making and using the same

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Deniz Kara et al., "Effectiveness of Human Amniotic Fluid and Amniotic Membrane in Preventing Spinal Epidural Fibrosis in An Experimental Rat Model", J.Neurol.Sci.[Turk], (2015), vol 32, no. 2, pages 293 - 302. *

Also Published As

Publication number Publication date
AU2017237093A1 (en) 2018-10-18
AU2023201219A1 (en) 2023-04-06
US11865142B2 (en) 2024-01-09
EP3432896A1 (en) 2019-01-30
WO2017165698A1 (en) 2017-09-28
EP3432896A4 (en) 2020-01-15
US10960027B2 (en) 2021-03-30
JP2019513136A (ja) 2019-05-23
US20200129562A1 (en) 2020-04-30
US20210283190A1 (en) 2021-09-16

Similar Documents

Publication Publication Date Title
US11865142B2 (en) Compositions and methods of treatment with amniotic fluid
Sahu et al. Utility of nanomaterials in wound management
US12453743B2 (en) Mesenchymal stem cell (MSC) growth factor and extracellular vesicle preparation in frozen or powdered form and methods of use
CN111848832B (zh) 含氟化合物修饰的阳离子聚合物作为药物载体的应用及制备方法
KR101004551B1 (ko) 조직유착 방지액 및 조직유착 방지방법
ES2490715T3 (es) Composiciones que comprenden células fetales no diferenciadas para el tratamiento de trastornos cutáneos
WO2008037262A1 (en) Wound healing composition comprising phosphate, iron and copper
KR102161850B1 (ko) 히알루론산과 동결건조된 줄기세포 유래 엑소좀의 조합을 유효성분으로 포함하는 창상 치료 또는 창상 치료 촉진용 조성물
EP3946289B1 (en) Vitamin a for use in the treatment of tendon injury or ligament injury
CN108135965B (zh) 用于伤口愈合的含p物质的药物组合物
KR20150128481A (ko) 세포외기질 및 온도감응성 고분자를 포함하는 생체 피부용 조성물
KR20210075051A (ko) 하이드로젤 패치를 포함하는 상처 또는 흉터 치료용 조성물
CA2551613A1 (en) A composition comprising n-acetyl-d-glucosamine for treatment of wound
ES2755055T3 (es) Composición para el tratamiento de lesiones tisulares
AU781964B2 (en) Non-solid composition for local application
CN107446018B (zh) 促进伤口愈合的肽及其应用
TW202502805A (zh) 新多功能寡肽
RU2173155C1 (ru) Ранозаживляющий, противовоспалительный и противоинфекционный лекарственный препарат
CN112206281A (zh) 一种抗感染修复创面的药物组合物及其制备方法与应用
WO2025087269A1 (en) New short-chain peptides and derivatives thereof
Tiwari et al. Local Drug Delivery Strategies towards Wound Healing. Pharmaceutics 2023, 15, 634
KR20250126174A (ko) 염기성 섬유아세포 성장인자가 담지된 인간 혈청 알부민 기반 단백질 나노입자 및 이의 제조방법
HK40082364A (en) Topical formulations comprising combinations of montelukast and mussel adhesion proteins
WO2025247002A1 (zh) 皮肤再生组合物及其用于处理皮肤的用途
WO2025252795A1 (en) Galactose and fucose monosaccharides for re-epithelialization and treating lesions

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)